美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · DMRA近 30 天 0 則 · 第 1 / 1 頁
- Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
- Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
- Damora Announces Redomestication from Delaware to Cayman Islands
- Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
- What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For Shareholders
- Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer
- Assessing Damora Therapeutics (DMRA) Valuation After CFO Transition And Recent Share Price Momentum
- How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%
- Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
- Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。